We are live on ! Find out more
PCM

Parsifal Capital Management Portfolio holdings

AUM $849M
1-Year Est. Return 28.52%
This Fund
S&P 500
This Quarter Est. Return
+15.69%
1 Year Est. Return
+28.52%
3 Year Est. Return
+104.05%
5 Year Est. Return
+98.76%
10 Year Est. Return
AUM
$1.22B
AUM Growth
+$145M
Cap. Flow
+$28.5M
Cap. Flow %
2.34%
Top 10 Hldgs %
75.52%
Holding
22
New
6
Increased
5
Reduced
7
Closed
4

Top Buys

Rank Stock Value
1
AXTA icon
Axalta
AXTA
+$64.1M
2
VIAV icon
Viavi Solutions
VIAV
+$54.7M
3
CORZ icon
Core Scientific
CORZ
+$20.9M
4
TEVA icon
Teva Pharmaceuticals
TEVA
+$19.9M
5
IESC icon
IES Holdings
IESC
+$14.2M

Top Sells

Rank Stock Value
1
DLTR icon
Dollar Tree
DLTR
+$99.3M
2
ACI icon
Albertsons Companies
ACI
+$75.6M
3
AVPT icon
AvePoint
AVPT
+$65.9M
4
SXT icon
Sensient Technologies
SXT
+$46.8M
5
LPX icon
Louisiana-Pacific
LPX
+$28.7M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 25.35%
2 Healthcare 20.04%
3 Industrials 16.09%
4 Technology 10.65%
5 Materials 5.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SN icon
1
SharkNinja
SN
$22.9B
$134M 11.01%
1,199,937
+116,337
+11% +$11.5M
HGV icon
2
Hilton Grand Vacations
HGV
$3.59B
$111M 9.09%
2,475,501
+278,221
+13% +$11.8M
COMP icon
3
CALL
Compass
COMP
$8.51B
$107M 8.76%
+10,110,100
New +$92.2M
GMED icon
4
Globus Medical
GMED
$10.7B
$107M 8.76%
1,222,717
+118,385
+11% +$8.99M
WBD icon
5
CALL
Warner Bros
WBD
$65.9B
$96.7M 7.93%
+3,356,800
New +$78.5M
TEVA icon
6
Teva Pharmaceuticals
TEVA
$40.8B
$88M 7.22%
2,819,933
+809,426
+40% +$19.9M
GXO icon
7
GXO Logistics
GXO
$5.77B
$75.9M 6.22%
1,441,613
-41,344
-3% -$2.17M
AXTA icon
8
Axalta
AXTA
$7.66B
$70.6M 5.79%
+2,184,355
New +$64.1M
MMM icon
9
3M
MMM
$90.9B
$66.8M 5.48%
417,358
-166,500
-29% -$27.2M
ATMU icon
10
Atmus Filtration Technologies
ATMU
$4.22B
$64.1M 5.26%
1,234,287
-8,733
-0.7% -$423K
VIAV icon
11
Viavi Solutions
VIAV
$9.12B
$60.3M 4.95%
+3,385,700
New +$54.7M
AVPT icon
12
AvePoint
AVPT
$2.76B
$52.1M 4.27%
3,752,179
-4,770,561
-56% -$65.9M
UNH icon
13
UnitedHealth
UNH
$376B
$49.6M 4.07%
150,258
-4,342
-3% -$1.47M
ACI icon
14
Albertsons Companies
ACI
$5.62B
$42.4M 3.48%
2,469,593
-4,239,655
-63% -$75.6M
IESC icon
15
IES Holdings
IESC
$14.8B
$39M 3.2%
100,180
+35,380
+55% +$14.2M
Z icon
16
PUT
Zillow
Z
$7.79B
$23M 1.89%
+337,800
New +$24.5M
CORZ icon
17
Core Scientific
CORZ
$6.66B
$17.4M 1.43%
+1,197,600
New +$20.9M
LPX icon
18
Louisiana-Pacific
LPX
$5.06B
$14.6M 1.19%
180,168
-339,432
-65% -$28.7M
CVS icon
19
CVS Health
CVS
$133B
-182,300
Closed -$13.7M
DLTR icon
20
Dollar Tree
DLTR
$24.4B
-1,052,185
Closed -$99.3M
HUM icon
21
Humana
HUM
$43.7B
-44,000
Closed -$11.4M
SXT icon
22
Sensient Technologies
SXT
$5.26B
-498,500
Closed -$46.8M

Similar funds

Parsifal Capital Management's Q4 2025 Portfolio in Review

As of Q4 2025, Parsifal Capital Management held 22 positions worth $1.22B, up 13% from $1.07B the previous quarter. Its ten largest holdings account for 76% of the portfolio.

Parsifal Capital Management's Q4 2025 filing shows 6 new, 5 increased, 7 reduced and 4 closed positions. Its largest new stake was Axalta: 2,184,355 shares worth $70.6M. The largest sale was Dollar Tree, an estimated $99.3M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Industrials.

  • Parsifal Capital Management's largest Q4 2025 buy was Axalta: 2,184,355 shares worth $70.6M.
  • Parsifal Capital Management added most to Teva Pharmaceuticals in Q4 2025, an estimated $19.9M increase.
  • Parsifal Capital Management's biggest Q4 2025 reduction was Albertsons Companies, cutting an estimated $75.6M.
  • Parsifal Capital Management fully exited Dollar Tree in Q4 2025, selling an estimated $99.3M.
  • Parsifal Capital Management's ten largest holdings make up 76% of its $1.22B portfolio in Q4 2025.
  • Parsifal Capital Management opened 6 new positions and closed 4 in Q4 2025.
  • Parsifal Capital Management's portfolio value rose 13% quarter-over-quarter to $1.22B.

Based on Parsifal Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.